Q3 Medical Group Information

Q3 Medical Group is a Dublin, Ireland based holding company formed April 17, 2013 by an international group of entrepreneurs, manufactures, distributors, industry doctors, and investors focused on the development and acquisition of medical device businesses with annual revenues between 1 -10 Million. Q3 Medical is focused on targeted acquisitions that will help facilitate the collective vertical independence of its member groups through the addition of key manufacturing, distribution, or technology-based business that improve margin, reduce cost, and help minimize reliance on external channel participants. The Company is currently implementing SAP Globally to allow for ease of reporting, monitoring, process optimization and efficiency management while providing for a scalable platform for future integrations. Q3 Medical is focused on maximizing its value through the continued product development and channel expansion and the improvement of operating efficiencies and enhanced financial synergies between its member companies. The wholly owned subsidiaries are primarily focused on the development, manufacturing, and sales of interventional Cardiology, Peripheral Vascular, and Non-Vascular technologies with an emphasis on Three Verticals where it believes it can achieve a 1st or 2nd market position. The three Verticals consist of novel bioresorbable implants, micro invasive technology, and drug delivery devices to treat patients with various cardiac, peripheral vascular, or oncology related issues. The Company expects to launch its second Bioresorbable product as well as several of its Micro Invasive and Drug Delivery technologies over the next 12 months.